Literature DB >> 3190195

Antibacterial activity of HRE 664, a new parenteral penem.

W Cullmann1, M Stieglitz.   

Abstract

The antibacterial activity of the new penem compound HRE 664 was evaluated in 451 clinical isolates, including ampicillin-resistant members of the family Enterobacteriaceae, Acinetobacter spp., Haemophilus influenzae, Staphylococcus aureus, and beta-hemolytic streptococci, and compared with those of piperacillin, ceftazidime, ceftriaxone, aztreonam, imipenem, and the penem compound Sch 34343. The new agent HRE 664 exhibited antibacterial activity comparable to that of the penem Sch 34343 and imipenem. The MICs of the new agent HRE 664 for 90% of the strains tested ranged from 1 to 4 micrograms/ml against Enterobacteriaceae and were 0.06 micrograms/ml for Staphylococcus aureus and 0.125 micrograms/ml for beta-hemolytic streptococci.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190195      PMCID: PMC172351          DOI: 10.1128/AAC.32.7.1090

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  The detection of methicillin resistance in Staphylococcus aureus.

Authors:  J H Hewitt; A W Coe; M T Parker
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

2.  HRE 664, a new parenteral penem. I. Antibacterial activity in vitro.

Authors:  G Seibert; D Isert; N Klesel; M Limbert; A Pries; E Schrinner; M Cooke; J Walmsley; P H Bentley
Journal:  J Antibiot (Tokyo)       Date:  1987-05       Impact factor: 2.649

3.  Sch 29482--a novel penem antibiotic: an in-vitro comparison of its activity with other beta-lactams.

Authors:  R M Brown; R Wise; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

4.  Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Authors:  I Phillips; A King; K Shannon; C Warren
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

5.  Synthesis of Sch 29482--a novel penem antibiotic.

Authors:  A K Ganguly; V M Girijavallabhan; S McCombie; P Pinto; R Rizi; P D Jeffrey; S Lin
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

6.  In vitro activity of CGP 31608, a new penem.

Authors:  R Wise; J M Andrews; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Authors:  K Shannon; A King; I Phillips
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

8.  In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.

Authors:  R N Jones; A L Barry; P C Fuchs; C Thornsberry
Journal:  J Antimicrob Chemother       Date:  1985-06       Impact factor: 5.790

9.  In vitro activity and beta-lactamase stability of a new penem, CGP 31608.

Authors:  H C Neu; N X Chin; N M Neu
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

  9 in total
  1 in total

1.  Use of the chromosomal class A beta-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds.

Authors:  M Galleni; N Franceschini; B Quinting; L Fattorini; G Orefici; A Oratore; J M Frère; G Amicosante
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.